Minerva Surgical, Inc. (UTRS)
OTCMKTS: UTRS · Delayed Price · USD
0.635
+0.085 (15.45%)
Mar 27, 2024, 12:03 PM EDT - Market closed

Minerva Surgical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
50.2952.137.7726.01
Revenue Growth (YoY)
-3.47%37.96%45.19%-
Cost of Revenue
23.0521.5818.6514.21
Gross Profit
27.2430.5219.1211.81
Selling, General & Admin
52.754.3831.1930.51
Research & Development
5.445.293.320.94
Other Operating Expenses
-0.07-0.340.070.17
Operating Expenses
58.1459.6734.5131.44
Operating Income
-30.9-29.15-15.39-19.64
Interest Income
0.090.010.080.14
Interest Expense
3.2211.7312.1417.58
Other Expense / Income
0.07-19.41-9.0514.97
Pretax Income
-34.1-21.46-18.4-52.05
Income Tax
0.010.01-0.1317.75
Net Income
-34.11-21.46-18.26-69.8
Shares Outstanding (Basic)
1011
Shares Outstanding (Diluted)
1011
Shares Change
310.83%-65.62%10.02%-
EPS (Basic)
-23.68-61.22-17.91-75.29
EPS (Diluted)
-23.68-61.22-17.91-75.29
Free Cash Flow
-35.64-22.96-12.69-20.02
Free Cash Flow Per Share
-24.74-65.49-12.45-21.59
Gross Margin
54.17%58.58%50.62%45.38%
Operating Margin
-61.44%-55.94%-40.75%-75.49%
Profit Margin
-67.83%-41.20%-48.36%-268.32%
Free Cash Flow Margin
-70.86%-44.07%-33.61%-76.95%
EBITDA
-30.88-18.86-8.16-17.66
EBITDA Margin
-61.40%-36.19%-21.61%-67.88%
Depreciation & Amortization
10.8110.627.081.68
EBIT
-41.69-29.48-15.24-19.33
EBIT Margin
-82.88%-56.57%-40.35%-74.32%
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.